Cargando…

Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease

Seed amplification assays (SAA) are the first credible molecular assay for Parkinson’s disease (PD). However, the value of SAA to support the clinicians’ initial diagnosis of PD is not clear. In our study, we analyzed cerebrospinal fluid samples from 121 PD patients recruited through population scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oftedal, Linn, Maple-Grødem, Jodi, Tysnes, Ole-Bjørn, Alves, Guido, Lange, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473053/ https://www.ncbi.nlm.nih.gov/pubmed/37393438 http://dx.doi.org/10.3233/JPD-230065

Ejemplares similares

Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders
por: Pedersen, Camilla Christina, et al.
Publicado: (2023)

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid
por: Oftedal, Linn, et al.
Publicado: (2020)

Parkinson’s disease clinical milestones and mortality
por: Gonzalez, Maria Camila, et al.
Publicado: (2022)

Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population
por: Lange, Johannes, et al.
Publicado: (2015)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease
por: Gaare, Johannes J., et al.
Publicado: (2018)

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection
por: Gjerstad, Michaela D., et al.
Publicado: (2018)

Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2017)

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Pedersen, Camilla Christina, et al.
Publicado: (2021)

Genetic risk scores and hallucinations in patients with Parkinson disease
por: Kusters, Cynthia D.J., et al.
Publicado: (2020)

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
por: Concha‐Marambio, Luis, et al.
Publicado: (2021)

Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
por: Tufekcioglu, Zeynep, et al.
Publicado: (2023)

Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Reliability of Three Disability Scales for Detection of Independence Loss in Parkinson's Disease
por: Bjornestad, Anders, et al.
Publicado: (2016)

Evolution of impulsive–compulsive behaviors and cognition in Parkinson’s disease
por: Erga, Aleksander H., et al.
Publicado: (2019)

Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
por: Dick, Fiona, et al.
Publicado: (2023)

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
por: Counsell, Carl, et al.
Publicado: (2022)

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study
por: Szwedo, Aleksandra A., et al.
Publicado: (2022)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
por: Green, Samantha, et al.
Publicado: (2021)

Amplification of Chromosome 1q Predicts Poor Overall Survival in Newly Diagnosed Multiple Myeloma Patients
por: Skerget, Matevz, et al.
Publicado: (2023)

Differential transcript usage in the Parkinson’s disease brain
por: Dick, Fiona, et al.
Publicado: (2020)

Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays
por: Consonni, Alessandra, et al.
Publicado: (2022)

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
por: Chahine, Lana M., et al.
Publicado: (2023)

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci
por: Gaare, Johannes Jernqvist, et al.
Publicado: (2020)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Early constipation predicts faster dementia onset in Parkinson’s disease
por: Camacho, M., et al.
Publicado: (2021)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
por: Nido, Gonzalo S., et al.
Publicado: (2020)

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
por: Toker, Lilah, et al.
Publicado: (2021)

The Future of Seed Amplification Assays and Clinical Trials
por: Coysh, Thomas, et al.
Publicado: (2022)

Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study
por: Erga, Aleksander H., et al.
Publicado: (2017)

NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study
por: Brakedal, Brage, et al.
Publicado: (2021)

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
por: Gaare, Johannes J, et al.
Publicado: (2018)

Development of a constitutive and an auto-inducible high-yield expression system for recombinant protein production in the microalga Nannochloropsis oceanica
por: de Grahl, Imke, et al.
Publicado: (2020)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Russo, Marco J., et al.
Publicado: (2021)

Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates
por: Middleton, John Stephen, et al.
Publicado: (2023)

Incidence of newly diagnosed diabetes after Covid-19
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c2a1tugc0ren4jdu147q65og3k